TOP HEADLINES

FEATURED STORY

  • Charles River embraces discovery in management shake-up

    Charles River Laboratories' longtime chief financial officer is stepping down in a planned retirement, giving the preclinical CRO a chance to further integrate its recent acquisitions and increase its focus on drug discovery.

INC Research soars in its first post-IPO quarter

Months removed from a $150 million IPO, INC Research is looking to raise its profile among the world's largest CROs, inching toward the $1 billion annual revenue mark in the new year.

Catalent beefs up its European network for clinical supplies

Catalent is investing in infrastructure again, spending to flesh out its European network of storage and packaging facilities in response to an increase in demand on the continent.

Enteris gets into contract manufacturing with new plant

Enteris BioPharma is looking to make some money on the side of its drug-delivery operation, opening a contract manufacturing facility and scouting for clients.

LabCorp seals its $6B deal for Covance

One of the world's largest CROs is no longer an independent entity as Covance has folded into testing giant LabCorp, closing a $6 billion deal and altering the industry landscape.

Quintiles shedding 270 jobs in a cost-cutting move

Global CRO Quintiles is planning to lay off about 270 workers, 1% of its payroll, in an effort to reduce "excess capacity," the company said.

MORE NEWS

From Our Sister Sites

FierceMedicalDevices

GE Ventures and Stanford Health Care (affiliated with Stanford University) just announced the launch of digital medicine company Evidation Health.

FierceMedicalDevices

The FDA's lead spokesperson, Karen Riley, said she doesn't know why the agency didn't discover that Olympus' now discredited duodenoscope was being marketed without the agency's required clearance.